Acquires 31.5% Stake, Secures Production Base for Hyaluronidase Raw Materials
Huons Acquires PanGen... “Expanding CDMO Services for Biopharmaceuticals”
Huons is set to expand its biopharmaceutical R&D and contract development and manufacturing organization (CDMO) services with its acquisition of PanGen, a specialized biopharmaceutical…